Electromed (ELMD) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.22% |
| Dec 31, 2025 | 72.83% |
| Sep 30, 2025 | 79.72% |
| Jun 30, 2025 | -16.10% |
| Mar 31, 2025 | -11.93% |
| Dec 31, 2024 | -24.28% |
| Sep 30, 2024 | -55.58% |
| Jun 30, 2024 | -25.97% |
| Mar 31, 2024 | -31.49% |
| Dec 31, 2023 | -8.70% |
| Sep 30, 2023 | 59.90% |
| Jun 30, 2023 | 23.79% |
| Mar 31, 2023 | 28.71% |
| Dec 31, 2022 | 27.35% |
| Sep 30, 2022 | 20.46% |
| Jun 30, 2022 | 18.19% |
| Mar 31, 2022 | 24.20% |
| Dec 31, 2021 | 5.61% |
| Sep 30, 2021 | 35.39% |
| Jun 30, 2021 | -8.13% |
| Mar 31, 2021 | -7.55% |
| Dec 31, 2020 | -13.89% |
| Sep 30, 2020 | -30.82% |
| Jun 30, 2020 | -8.69% |
| Mar 31, 2020 | -2.42% |
| Dec 31, 2019 | 15.48% |
| Sep 30, 2019 | 20.91% |
| Jun 30, 2019 | 30.78% |
| Mar 31, 2019 | -25.86% |
| Dec 31, 2018 | -4.67% |
| Sep 30, 2018 | -41.24% |
| Jun 30, 2018 | -13.85% |
| Mar 31, 2018 | -7.65% |
| Dec 31, 2017 | -14.12% |
| Sep 30, 2017 | -13.57% |
| Jun 30, 2017 | 28.37% |
| Mar 31, 2017 | 6.25% |
| Dec 31, 2016 | -11.62% |
| Sep 30, 2016 | -25.49% |
| Jun 30, 2016 | 13.02% |
| Mar 31, 2016 | -6.77% |
| Dec 31, 2015 | -6.22% |
| Sep 30, 2015 | 0.70% |